France Network Point-of-care Glucose Testing Market Size & Outlook

The network point-of-care glucose testing market in France is expected to reach a projected revenue of US$ 74.5 million by 2030. A compound annual growth rate of 2.7% is expected of France network point-of-care glucose testing market from 2024 to 2030.
Revenue, 2023 (US$M)
$61.6
Forecast, 2030 (US$M)
$74.5
CAGR, 2024 - 2030
2.7%
Report Coverage
France

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

France network point-of-care glucose testing market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

France network point-of-care glucose testing market highlights

  • The France network point-of-care glucose testing market generated a revenue of USD 61.6 million in 2023 and is expected to reach USD 74.5 million by 2030.
  • The France market is expected to grow at a CAGR of 2.7% from 2024 to 2030.
  • In terms of segment, accu-chek inform ii was the largest revenue generating product in 2023.
  • CareSens Expert Plus is the most lucrative product segment registering the fastest growth during the forecast period.


Network point-of-care glucose testing market data book summary

Market revenue in 2023USD 61.6 million
Market revenue in 2030USD 74.5 million
Growth rate2.7% (CAGR from 2024 to 2030)
Largest segmentAccu-chek inform ii
Fastest growing segmentCareSens Expert Plus
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationI-STAT, CareSens Expert Plus, Accu-Chek Inform II, StatStrip, HemoCue
Key market players worldwideRoche Holding AG ADR, Abbott Laboratories, Nova Biomedical, Bayer AG, Danaher Corp


Other key industry trends

  • In terms of revenue, France accounted for 4.6% of the global network point-of-care glucose testing market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany network point-of-care glucose testing market is projected to lead the regional market in terms of revenue in 2030.
  • Italy is the fastest growing regional market in Europe and is projected to reach USD 53.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Network Point-of-Care Glucose Testing Market Companies

Name Profile # Employees HQ Website
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Nova Biomedical View profile 501-1000 Waltham, Massachusetts, United States, North America http://www.novabio.us
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com
Roche Holding AG ADR View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com

France network point-of-care glucose testing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to network point-of-care glucose testing market will help companies and investors design strategic landscapes.


Accu-chek inform ii was the largest segment with a revenue share of 49.51% in 2023. Horizon Databook has segmented the France network point-of-care glucose testing market based on i-stat, caresens expert plus, accu-chek inform ii, statstrip, hemocue covering the revenue growth of each sub-segment from 2018 to 2030.


Diabetes has been a key factor responsible for dialysis, amputations, and blindness in adults in France. Presence of international glucose testing manufacturers is expected to help reduce these complications in patients suffering from diabetes and aid in better disease management.

Moreover, international manufacturers have a strong network in the country, which is expected to increase the distribution of glucose testing products.

Reasons to subscribe to France network point-of-care glucose testing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of France network point-of-care glucose testing market databook

  • Our clientele includes a mix of network point-of-care glucose testing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the France network point-of-care glucose testing market , including forecasts for subscribers. This country databook contains high-level insights into France network point-of-care glucose testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

France network point-of-care glucose testing market size, by product, 2018-2030 (US$M)

France Network Point-of-Care Glucose Testing Market Outlook Share, 2023 & 2030 (US$M)

France network point-of-care glucose testing market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online